Management of bronchial secretions with Free Aspire in children with cerebral palsy: impact on clinical outcomes and healthcare resources

Italian Journal of Pediatrics
Giancarlo GarutiMirco Lusuardi

Abstract

Management of secretions in children with cerebral palsy is often problematic due to severe deformation of the rib cage, impaired cough, and patients'inability to collaborate with chest physiotherapy. Assessing the effectiveness of different methods and techniques of secretion clearance is hampered by the lack of direct outcome measures and by limited patient cooperation. This observational study was planned to evaluate the efficacy of Free Aspire, a device that utilizes a special method to remove secretions from the bronchial tree in hypersecretive patients. Cerebral palsy patients were selected who had experienced more than 3 episodes of respiratory exacerbations in the latest year despite therapeutic optimization (including bronchial clearance techniques) and who had received at least one antibiotic course or underwent at least one access to the Emergency Room (ER) or admission to hospital in the 6 months prior to the study. Patients with congestive heart failure or contraindications for Free Aspire were excluded. We prospectively enrolled 8 patients (mean age 8.25 ± 6.11 years) who had been using in the past techniques for clearance secretions different from Free Aspire. The treatment with Free Aspire consisted of at least ...Continue Reading

References

Jan 14, 1999·Journal of Neurology, Neurosurgery, and Psychiatry·M I PolkeyP N Leigh
Oct 16, 1999·Archives of Disease in Childhood·G MaudsleyP O Pharoah
May 1, 2001·Journal of Paediatrics and Child Health·D S ReddihoughJ E Walstab
Dec 24, 2002·Archives of Disease in Childhood·P C Seddon, Y Khan
Jan 19, 2006·Developmental Medicine and Child Neurology·Karla HemmingPeter O D Pharoah
Jun 6, 2009·Journal of Paediatrics and Child Health·Gordon BaikieDavid J Cook
Jun 17, 2010·Archives of Disease in Childhood·Gillian BairdDiana Elbourne
Sep 18, 2012·Acta Physiologica Hungarica·P BorkaJ Bódis

❮ Previous
Next ❯

Citations

Oct 16, 2018·Developmental Medicine and Child Neurology·Lieve BoelStijn Verhulst
Mar 21, 2018·Archives of Disease in Childhood·Amanda Marie BlackmoreAndrew C Wilson
Jul 6, 2019·Child: Care, Health and Development·Amanda Marie BlackmoreAndrew C Wilson
Aug 8, 2019·The Clinical Respiratory Journal·Stefano BelliBruno Balbi
Jul 1, 2020·Italian Journal of Pediatrics·Liqin HuJungao Huang
Jul 17, 2020·Frontiers in Pediatrics·Rachael MarpoleAndrew C Wilson
Aug 18, 2020·Developmental Medicine and Child Neurology·Noula GibsonAndrew C Wilson
Feb 27, 2021·Frontiers in Medicine·Stefano BelliBruno Balbi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.